Olink Holding AB ADR OLK
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OLK is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $24.01
- Day Range
- $23.66–24.01
- 52-Week Range
- $14.10–26.01
- Bid/Ask
- $19.00 / $24.49
- Market Cap
- $2.98 Bil
- Volume/Avg
- 312,482 / 493,946
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 17.43
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Olink Holding AB has a proprietary and patented Proximity Extension Assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of labs and installed instrumentation. It has two segments including Kit and Services. It derives revenues from Sweden, the United States which also generates key revenue, China, EMEA (Excluding Sweden) Japan, and other regions.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- —
- Total Number of Employees
- 707
- Website
- https://www.olink.com
Valuation
|
Metric
|
OLK
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 6.45 |
Price/Sales | 17.43 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
OLK
|
|---|---|
Quick Ratio | 3.91 |
Current Ratio | 5.60 |
Interest Coverage | −46.44 |
Quick Ratio
OLK
Profitability
|
Metric
|
OLK
|
|---|---|
Return on Assets (Normalized) | −4.31% |
Return on Equity (Normalized) | −5.00% |
Return on Invested Capital (Normalized) | −5.86% |
Return on Assets
OLK
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Msxslktsmb | Xykt | $227.9 Bil | |
DHR
| Danaher Corp | Jjfmvtgqp | Chtmtxb | $196.2 Bil | |
A
| Agilent Technologies Inc | Fgxtczsgw | Dql | $45.2 Bil | |
IDXX
| IDEXX Laboratories Inc | Xgrhfcwg | Hnsxdl | $44.7 Bil | |
IQV
| IQVIA Holdings Inc | Ccbqgrdv | Tfmcbfn | $42.8 Bil | |
MTD
| Mettler-Toledo International Inc | Lwxrgprdnd | Zlfwvgg | $32.7 Bil | |
ICLR
| Icon PLC | Lnjnbyj | Dtyxcq | $26.1 Bil | |
WAT
| Waters Corp | Hpxrtdbqn | Jbr | $21.4 Bil | |
ILMN
| Illumina Inc | Cmhctjljh | Svwsgn | $18.2 Bil | |
LH
| Laboratory Corp of America Holdings | Gpjjgpcw | Spbrzd | $18.0 Bil |